201249

137. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status
of p16 protein is associated with human papillomavirus oncogenic potential in
cervical and genital lesions. Am J Pathol 1998;153:1741 – 8
138. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry
improves interobserver agreement in the diagnosis of cervical intraepithelial
neoplasia. Am J Surg Pathol 2002;26:1389 – 99
139. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. p16(INK4a)
expression correlates with degree of cervical neoplasia: a comparison with Ki-67
expression and detection of high-risk HPV types. Mod Pathol 2003;16:665 – 73
140. Wang SS, Trunk M, Schiffman M, et al. Validation of p16INK4a as a marker
of oncogenic human papillomavirus infection in cervical biopsies from a
population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers
Prev2004;13:1355 – 60
141. Hu L, Guo M, He Z, Thornton J, McDaniel LS, Hughson MD. Human
papillomavirus genotyping and p16INK4a expression in cervical intraepithelial
neoplasia of adolescents. Mod Pathol 2005;18:267 – 73
142. Benevolo M, Mottolese M, Marandino F, et al. Immunohistochemical
expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade
lesions. Mod Pathol 2006;19:384 – 91
143. Focchi GR, Silva ID, Nogueira-de-Souza NC, Dobo C, Oshima CT, Stavale
JN. Immunohistochemical expression of p16(INK4A) in normal uterine cervix,
nonneoplastic epithelial lesions, and low grade squamous intraepithelial lesions. J
Low Genit Tract Dis 2007; 11:98 – 104
144. Sahebali E., Ki-67 immunocytochemistry in liquid based cervical cytology:
useful as an adjunctive tool? J Clin Pathol 2003;56:681-686
145. Lilli, F.B.(2005). Determination of human papillomavirus (HPV) load and type
in highgrade cervical lesions surgically resected from HIV-infected women during
followup of HPV infection. Clin Infect Dis 40, 451-457
146. Xi, L.F., Hughes, J.P., Castle, P.E., Edelstein, Z.R., Wang, C., Galloway,
D.A., Koutsky, L.A., Kiviat ,N.B. & Schiffman, M. (2011). Viral load in the natural
history of human papillomavirus type 16 infection: a nested case-control study. J
Infect Dis 15;203(10): 1425-1433
147. Denis, F., Hanz, S. & Alain, S.(2008). Clearance, persistence and recurrence
of HPV infection. Gynecol Obstet Fertil 36: 430-440
148. Zappacosta, R., Caraceni, D., Ciccocioppo, L., Ottaviantonio, M., Conti, F.,
Andreozzi, S., Petrucci, F. & Rosini S. (2010). Is HPV-DNA testing a useful tool in
predicting low grade squamous intraepithelial lesion outcome? A retrospective
longitudinal study. Int J Immunopathol Pharmacol 23(1): 317-326
149. Cuschieri et. al., Assessment of human papillomavirus mRNA detection over
time in cervical specimens collected in liquid based cytology medium. 2005;124(1-
2):211-215
150. Powell et al. Recovery of human papillomavirus nucleic acids from liquidbased
cytology media. 2006;137(1):58-62
151. Cuschieri et. al., Human Papillomavirus mRNA and p16 Detection as
Biomarkers for the Improved Diagnosis of Cervical Neoplasia. Cancer Epidemiol
Biomarkers PrevOctober 2008 17; 2536
152. Xiao W, Bian M, Ma L, Liu J, Chen Y, Yang B, Wu Q: Immunochemical
analysis of human papillomavirus L1 capsid protein in liquidbased cytology
samples from cervical lesions. Acta Cytol 2010; 54: 661–667
153. Sarmadi S, Izadi-Mood N, Pourlashkari M, Yarandi F, Sanii S: HPV L1
capsid protein expression in squamous intraepithelial lesions of cervix uteri and its
relevance to disease outcome. Arch Gynecol Obstet 2011, E-pub ahead of print
93